Established in 2003, Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. Its technological advance in detecting fluorescence of Advanced Glycation Endproducts (AGEs) has led to the invention of the AGE Reader™ – a state of art diagnostic device which can determine the tissue accumulation of AGEs in 30 seconds.
Diagnoptics introduced the AGE Reader mu in 2013. This next generation AGE Reader has the same high measurement quality standard and combines this with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors.
Company’s Keywords:
diabetes screening, cardiovascular risk assessment, medical technology, noninvasive technologies
<10
<7000000
<2003
Your request has been submitted successfully.
Own or work here?